Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Therapy areas
Immuno-oncology
Immuno-oncology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-oncology
PhRMA Predicts Dire Consequences for Pharma Industry if Pelosi Plan Passes
Biospace News
-
October 11, 2019
Immuno-oncology
Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors
Immuno-oncology
Selectively Targeting Cancerous T-Cells Using CAR-T Therapy
Immuno-oncology
Provectus Provides Update on GI Tumor Program for Investigational Cancer Drug PV-10
Immuno-oncology
MDNA55 Shows Promising Results in Models of Ovarian Cancer
Immuno-oncology
Bristol-Myers Squibb’s Opdivo Fails to Show Superiority to Bayer’s Nexavar in...
Biospace News
-
June 24, 2019
0
Immuno-oncology
ADC Therapeutics Presents Clinical Data on ADCT-402 and ADCT-301 in Subtypes...
Biospace News
-
June 21, 2019
0
Immuno-oncology
Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the...
Biospace News
-
June 20, 2019
0
Immuno-oncology
Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different...
Biospace News
-
May 23, 2019
0
Immuno-oncology
Polyphor Announces Presentation of New Survival Data on Balixafortide at the...
Biospace News
-
May 20, 2019
0
1
2
3
...
25
Page 1 of 25
- Advertisement -
MOST POPULAR
AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma
February 14, 2019
Vaccibody AS to present data on VB10.NEO and VB10.16 at upcoming...
February 28, 2019
Auris Medical Receives Positive Nasdaq Listing Determination
April 15, 2019
Oncopeptides AB: INTERIM REPORT Q1 2019
May 21, 2019
Load more
HOT NEWS
Others
BioSpace’s Global Biopharma Roundup: April 4
Phase I
Provention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical...
Commercial
Europe’s Peroxfarma Brings its Expertise in Joint Care to America
Acquisitions
Danaher to Acquire the Biopharma Business of General Electric Life Sciences...
